ATOS study: effectiveness and safety of insulin glargine 300 U/mL in the real world clinical practice in insulin-naïve type 2 diabetic patients in the Russian Federation
Rationale: Basal insulin glargine 300 U/mL (Gla-300) is a second-generation basal insulin analogue that has comparable efficacy and lower variability compared to the first generation long-acting insulin analogue glargine 100 U/mL. Aim: To assess the effectiveness and safety of Gla-300 in insulin-...
Αποθηκεύτηκε σε:
| Κύριος συγγραφέας: | |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Russo |
| Έκδοση: |
MONIKI
2022-10-01
|
| Σειρά: | Alʹmanah Kliničeskoj Mediciny |
| Θέματα: | |
| Διαθέσιμο Online: | https://almclinmed.ru/jour/article/viewFile/1723/1479 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|